Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aquavan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Fospropofol, a phosphorylated prodrug version of the popular induction agent propofol, is hydrolyzed in vivo to release active… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Review
2008
Review
2008
Propofol (2,6-diisopropylphenol) is inadequably soluble in water and is therefore formulated as a lipid emulsion. This may have… Expand
2008
2008
A novel ethyl dioxy phosphate prodrug of propofol (3) was synthesized and characterized in vitro and in vivo as safer alternative… Expand
Highly Cited
2007
Highly Cited
2007
Goal To determine rapidly acting agents' impact on practice efficiency and cost for outpatient colonoscopy in a screening… Expand
Review
2006
Review
2006
  • T. Gan
  • Clinical pharmacokinetics
  • 2006
  • Corpus ID: 19952165
The ability to deliver safe and effective moderate sedation is crucial to the ability to perform invasive procedures. Sedative… Expand
Highly Cited
2005
Highly Cited
2005
BACKGROUND AQUAVAN Injection (AQ) (GPI 15715; Guilford Pharmaceutical Inc., Baltimore, MD) is a water-soluble prodrug of propofol… Expand
Review
2005
Review
2005
  • M. Krasowski
  • Current opinion in investigational drugs
  • 2005
  • Corpus ID: 45766759
GPI-15715 (PQ-1002, Aquavan), a water-soluble prodrug of propofol, is being developed by Guilford, under license from ProQuest… Expand
Highly Cited
2003
Highly Cited
2003
BACKGROUND GPI 15715 (AQUAVAN injection) is a new water-soluble prodrug which is hydrolyzed to release propofol. The objectives… Expand
Highly Cited
2003
Highly Cited
2003
Background and objective: We studied the pharmacokinetics and pharmacodynamics of GPI 15715 (Aquavan® injection), a new water… Expand